Imperva Inc. said its first-quarter normalized net income came to a loss of 47 cents per share, compared with the S&P Capital IQ consensus estimate of a loss of 28 cents per share.
The per-share loss grew year over year from 45 cents.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was a loss of $15.0 million, compared with a loss of $12.2 million in the prior-year period.
The normalized profit margin increased to negative 25.1% from negative 27.4% in the year-earlier period.
Total revenue rose 33.6% on an annual basis to $59.8 million from $44.8 million, and total operating expenses rose 30.5% from the prior-year period to $84.0 million from $64.4 million.
Reported net income totaled a loss of $24.0 million, or a loss of 75 cents per share, compared to a loss of $20.0 million, or a loss of 74 cents per share, in the prior-year period.